Metformin Dosing Recommendations
Start metformin immediate-release at 500 mg or 850 mg once daily with meals, titrate upward by 500 mg weekly or 850 mg every 2 weeks to a maximum of 2550 mg/day in divided doses, with dose adjustments required when eGFR falls below 45 mL/min/1.73 m² 1, 2.
Initial Dosing
Immediate-Release Formulation
- Starting dose: 500 mg or 850 mg once daily with meals 1, 2
- Extended-release: Start at 500 mg once daily 1
The choice between 500 mg and 850 mg starting doses depends on tolerability concerns—the lower dose minimizes gastrointestinal side effects, which are the primary reason for discontinuation 3.
Titration Schedule
Titrate gradually to minimize gastrointestinal intolerance:
- Immediate-release: Increase by 500 mg/day or 850 mg every 7 days (weekly) until maximum dose 1, 2
- Extended-release: Increase by 500 mg/day every 7 days until maximum dose 1
The gradual weekly titration is critical—abrupt dose increases significantly worsen bloating, abdominal discomfort, and diarrhea 3.
Maximum Dosing
- Maximum daily dose: 2550 mg/day for immediate-release 2
- Practical maximum: 2000 mg/day is commonly used; doses above 2000 mg may be better tolerated when given three times daily with meals 2
- Pediatric maximum (age ≥10 years): 2000 mg/day in divided doses 2
Dose Adjustments Based on Kidney Function
Kidney function is the critical determinant for metformin dosing and safety 1:
eGFR ≥60 mL/min/1.73 m²
- Continue same dose
- Monitor kidney function at least annually 1
eGFR 45-59 mL/min/1.73 m²
- Continue same dose in most patients
- Consider dose reduction in certain conditions (concurrent illness, dehydration, contrast procedures) 1
- Monitor kidney function every 3-6 months 1
eGFR 30-44 mL/min/1.73 m²
- Halve the dose 1
- Do NOT initiate metformin if patient is treatment-naïve 1
- Monitor kidney function every 3-6 months 1
eGFR <30 mL/min/1.73 m²
Important Clinical Considerations
Monitoring Requirements
- Kidney function: At least annually when eGFR ≥60; every 3-6 months when eGFR <60 1
- Vitamin B12: Monitor for deficiency after >4 years of treatment 1
- Increase monitoring frequency when eGFR <60 mL/min/1.73 m² 1
Contrast Imaging Procedures
Discontinue metformin at the time of or prior to iodinated contrast procedures in patients with:
- eGFR 30-60 mL/min/1.73 m²
- History of liver disease, alcoholism, or heart failure
- Intra-arterial contrast administration
Re-evaluate eGFR 48 hours after imaging; restart only if renal function is stable 2.
Common Pitfalls
Underdosing is prevalent in clinical practice—real-world data shows only 21.8% of patients receive ≥1500 mg/day at initiation, and only 34.1% reach this dose within 6 months 4. This represents significant therapeutic inertia, as doses ≥1500 mg/day are often needed for optimal glycemic control.
Dose up-titration is frequently neglected—only 10.8% of patients have their dose increased within the first year despite inadequate glycemic control 5. Research demonstrates that patients whose metformin dose was up-titrated had twice the odds of achieving glycemic control compared to those not up-titrated 6.
Practical Dosing Algorithm
For patients with normal kidney function (eGFR ≥60):
- Week 1: Start 500 mg once daily with dinner (or 850 mg if well-tolerated)
- Week 2: Increase to 500 mg twice daily (morning and evening with meals)
- Week 3: Increase to 1000 mg morning + 500 mg evening
- Week 4: Increase to 1000 mg twice daily (2000 mg/day total)
- If needed: Further increase to 1000 mg morning + 1000 mg midday + 500-550 mg evening (maximum 2550 mg/day)
Target dose for most patients: 2000 mg/day in divided doses provides optimal efficacy while maintaining tolerability 2, 7.